35
Participants
Start Date
March 31, 2007
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
bevacizumab
fluorouracil
leucovorin calcium
oxaliplatin
conventional surgery
radiation therapy
Memorial Sloan-Kettering Cancer Center, New York
Collaborators (1)
National Cancer Institute (NCI)
NIH
Genentech, Inc.
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER